等待开盘 10-16 09:30:00 美东时间
0.000
0.00%
Korsana Biosciences, a biotech company developing therapies for neurodegenerative diseases, has completed its merger with Cyclerion Therapeutics and will begin trading on Nasdaq under "KRSA" on September 9. The company secured $380 million in private financing, bringing its cash reserves to approximately $475 million, which is expected to fund operations into 2029. Korsana's lead program, KRSA-028, a next-generation antibody targeting amyloid bet...
09-08 20:05
Cyclerion Therapeutics ( ($CYCN) ) has issued an announcement. At an annual sha...
08-27 18:27
Cyclerion Therapeutics (NASDAQ:CYCN) reported quarterly losses of $(0.76) per share. This is a 35.71 percent decrease over losses of $(0.56) per share from the same period last year.
05-13 05:32
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
04-10 03:30
Gainers Cyclerion Therapeutics (NASDAQ:CYCN) shares rose 307.1% to $6.31 durin...
04-02 01:06
Cyclerion Therapeutics shares are trading higher after the company announced it...
04-01 19:28